Latest News and Press Releases

CHARLOTTE, N.C., April 22, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release first quarter results for the period ended March 31, 2010...

CHARLOTTE, N.C., April 6, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 17th Annual Future Leaders in the Biotech Industry Conference...

Northera Effectively Increases SBP in Patients With Neurogenic Orthostatic Hypotension Patients Showed Mean Diurnal Increase of 8.4 mmHg SBP and Mean Nocturnal Increase of 7.8 mmHg SBP While...

CHARLOTTE, N.C., March 12, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the ROTH 21st Annual OC Growth Stock Conference at 11:00 AM PT on...

CHARLOTTE, N.C., March 10, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year 2009 and will host a...

CHARLOTTE, N.C., March 5, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it completed its previously announced registered direct offering to...

CHARLOTTE, N.C., March 3, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release fourth quarter and full year results for the period ended...

CHARLOTTE, N.C., Feb. 26, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced it has obtained commitments from institutional investors to purchase approximately...

CHARLOTTE, N.C., Feb. 11, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that a new investigator-led phase II clinical study of Droxidopa, an oral synthetic...

FDA Confirms Special Protocol Assessment for Study 301 Protocol for Study 306 Finalized, Study to Begin in the Second Quarter Northera Selected as US Brand Name for Droxidopa in...